Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure

Abstract In patients with heart failure (HF), the exhaled concentrations of hydrogen after a breath test—a non-invasive assessment of small intestinal overgrowth- has been related to HF severity and higher risk of adverse outcomes. Indeed, two intestinal bacterial metabolites—blood Trimethylamine N-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Mollar, Vannina G. Marrachelli, Eduardo Núñez, Daniel Monleon, Vicent Bodí, Juan Sanchis, David Navarro, Julio Núñez
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/cce0c779f69146fe855347fb475f4017
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:cce0c779f69146fe855347fb475f4017
record_format dspace
spelling oai:doaj.org-article:cce0c779f69146fe855347fb475f40172021-12-02T11:39:33ZBacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure10.1038/s41598-021-85527-52045-2322https://doaj.org/article/cce0c779f69146fe855347fb475f40172021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85527-5https://doaj.org/toc/2045-2322Abstract In patients with heart failure (HF), the exhaled concentrations of hydrogen after a breath test—a non-invasive assessment of small intestinal overgrowth- has been related to HF severity and higher risk of adverse outcomes. Indeed, two intestinal bacterial metabolites—blood Trimethylamine N-Oxide (TMAO) and butyrate—have been related to a worse prognosis in HF. However, the relationship between the exhaled concentrations of hydrogen after a breath test and these two metabolites remains unknown. Thus, in this post-hoc analysis, we sought to evaluate whether these two metabolites are associated with the exhaled concentrations of hydrogen after a breath test in patients with a recent admission for HF. We included 60 patients with a recent hospitalization for HF. Cumulative hydrogen over time was integrated into a single measurement by the area under the concentration curve (AUC-H2). A linear regression multivariable analysis was used to evaluate the associations. A 2-sided p-value < 0.05 was considered to be statistically significant. The median (p25–p75) amino-terminal pro-brain natriuretic peptide, AUC-H2, TMAO, and Butyrate were 4789 pg/ml (1956–11149), 1615 (700–2585), 0.68 (0.42–1.12), and 0.22 ± 13, respectively. After multivariate adjustment, TMAO and butyrate were significantly associated with AUC-H2 (p = 0.027 and p = 0.009, respectively). For TMAO, this association was positive and for butyrate, negative. Bacterial-origin metabolites TMAO and Butyrate were independently related to AUC-H2 in patients with a recent hospitalization for acute HF.Anna MollarVannina G. MarrachelliEduardo NúñezDaniel MonleonVicent BodíJuan SanchisDavid NavarroJulio NúñezNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Anna Mollar
Vannina G. Marrachelli
Eduardo Núñez
Daniel Monleon
Vicent Bodí
Juan Sanchis
David Navarro
Julio Núñez
Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
description Abstract In patients with heart failure (HF), the exhaled concentrations of hydrogen after a breath test—a non-invasive assessment of small intestinal overgrowth- has been related to HF severity and higher risk of adverse outcomes. Indeed, two intestinal bacterial metabolites—blood Trimethylamine N-Oxide (TMAO) and butyrate—have been related to a worse prognosis in HF. However, the relationship between the exhaled concentrations of hydrogen after a breath test and these two metabolites remains unknown. Thus, in this post-hoc analysis, we sought to evaluate whether these two metabolites are associated with the exhaled concentrations of hydrogen after a breath test in patients with a recent admission for HF. We included 60 patients with a recent hospitalization for HF. Cumulative hydrogen over time was integrated into a single measurement by the area under the concentration curve (AUC-H2). A linear regression multivariable analysis was used to evaluate the associations. A 2-sided p-value < 0.05 was considered to be statistically significant. The median (p25–p75) amino-terminal pro-brain natriuretic peptide, AUC-H2, TMAO, and Butyrate were 4789 pg/ml (1956–11149), 1615 (700–2585), 0.68 (0.42–1.12), and 0.22 ± 13, respectively. After multivariate adjustment, TMAO and butyrate were significantly associated with AUC-H2 (p = 0.027 and p = 0.009, respectively). For TMAO, this association was positive and for butyrate, negative. Bacterial-origin metabolites TMAO and Butyrate were independently related to AUC-H2 in patients with a recent hospitalization for acute HF.
format article
author Anna Mollar
Vannina G. Marrachelli
Eduardo Núñez
Daniel Monleon
Vicent Bodí
Juan Sanchis
David Navarro
Julio Núñez
author_facet Anna Mollar
Vannina G. Marrachelli
Eduardo Núñez
Daniel Monleon
Vicent Bodí
Juan Sanchis
David Navarro
Julio Núñez
author_sort Anna Mollar
title Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
title_short Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
title_full Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
title_fullStr Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
title_full_unstemmed Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
title_sort bacterial metabolites trimethylamine n-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/cce0c779f69146fe855347fb475f4017
work_keys_str_mv AT annamollar bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT vanninagmarrachelli bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT eduardonunez bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT danielmonleon bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT vicentbodi bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT juansanchis bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT davidnavarro bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
AT julionunez bacterialmetabolitestrimethylaminenoxideandbutyrateassurrogatesofsmallintestinalbacterialovergrowthinpatientswitharecentdecompensatedheartfailure
_version_ 1718395728698540032